Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

FDA clears new formulation of Imitrex

Sep. 1, 1997

FKBP12 inhibitors in the pipeline at Guilford

Aug. 29, 1997

New Parkinson's disease treatment option now available in Canada

Aug. 28, 1997

Morphine derivatives discovered by Nycomed

Aug. 28, 1997

Tasmar approved in EU for Parkinson's disease

Aug. 28, 1997

Neurochemical actions of ARL-12495AA, the active metabolite of remacemide

Aug. 28, 1997

Immune Response's TCR vaccine evaluated in MS patients

Aug. 28, 1997

Calcium channel antagonist AJ-3941 for treatment of stroke

Aug. 27, 1997

S-15535 tested in preclinical models of anxiety and depression

Aug. 27, 1997

New treatment option for cancer pain

Aug. 27, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 24, 2026.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld Science
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...